Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
04:45pm, Thursday, 16'th Mar 2023
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Novo Nordisk to lower prices of some insulins, following similar move by Lilly
08:45am, Tuesday, 14'th Mar 2023
Novo Nordisk DK:NOVO.B NVO said that it is lowering the prices of several insulin products by up to 75% starting in 2024. The company's U.S.-listed shares were up about 1.0% in premarket trading on Tu
Why Eli Lilly Stock Cruised to a 3% Gain on Monday
06:50pm, Monday, 13'th Mar 2023
Prominent stock watcher Wells Fargo became sharply more bullish on the company. Analyst Mohit Bansal upped his recommendation from hold to an effective buy.
Eli Lilly suffers setback in Alzheimer's treatment plans
01:00pm, Thursday, 09'th Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the setback Eli Lilly is facing for one of its Alzheimer's treatment drugs while it looks to a phase 3 trial for another drug.
Eli Lilly's Decade-Long Effort In Alzheimer's Disease Just Failed
09:37am, Thursday, 09'th Mar 2023
Eli Lilly stock and Biogen stock diverged Thursday after Lilly said a decade-long study of an Alzheimer's treatment definitively failed. The post Eli Lilly's Decade-Long Effort In Alzheimer's Disease
Eli Lilly first-generation Alzheimer's drug did not slow cognitive decline
03:34am, Thursday, 09'th Mar 2023
Eli Lilly and Co (NYSE:LLY)'s early-generation Alzheimer's drug, solanezumab, did not slow cognitive decline in patients treated before they showed symptoms, according to the results of a large trial.
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression
11:34pm, Wednesday, 08'th Mar 2023
Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.
Lilly's drug aimed at preventing Alzheimer's fails
05:54pm, Wednesday, 08'th Mar 2023
Eli Lilly & Co. said late Wednesday that a drug aimed at preventing Alzheimer's disease before symptoms start has failed to slow down cognitive decline in healthy older adults at risk of developing th
Eli Lilly's Insulin Decision Puts Others in Hot Seat
05:30am, Wednesday, 08'th Mar 2023
The drugmaker's plan moves the spotlight to industry middlemen, who face a barrage of investigations.
Lilly's (LLY) Verzenio Gets FDA Nod for Expanded Breast Cancer
12:02pm, Tuesday, 07'th Mar 2023
Eli Lilly (LLY) announces FDA approval of label expansion of Verzenio (abemaciclib), in combination with endocrine therapy, for treating HR+, HER2-, node-positive and high-risk early breast cancer.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Tuesday, 07'th Mar 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
WW Stock Soars As Telehealth Deal Opens Up Hot Obesity Drug Market
07:12am, Tuesday, 07'th Mar 2023
Former WeightWatchers is entering clinical weight management. WW stock surged.
7 High-Growth Stocks for ESG-Oriented Investors
11:19am, Sunday, 05'th Mar 2023
Generally, a perception exists that supporting environmental, social, and governance ( ESG ) initiatives may lead to expansion and profitability erosion, though the enthusiasm toward the following hig
AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam
08:59am, Saturday, 04'th Mar 2023
Arista Networks, which keeps popping up on lists of top AI stocks, leads this weekend's watch list of 5 stocks near buy points. The post AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Ral
Best Buy, Eli Lilly, Salesforce: Stocks That Defined the Week
06:07pm, Friday, 03'rd Mar 2023
Here are seven major companies whose stocks moved on the week's news.
